Biotest Aktiengesellschaft Defensive Interval Ratio
Biotest Aktiengesellschaft defensive interval ratio. Biotest Aktiengesellschaft (BIO3) has a Defensive Interval Ratio of 395 days as of March 2025. Defensive assets of €173.20 Million (cash €-, short-term investments €18.00 Million, receivables €155.20 Million) cover 395 days of daily cash needs of €438.63K/day. Explore BIO3 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Biotest Aktiengesellschaft (2008–2024)
Defensive interval ratio of Biotest Aktiengesellschaft from 2008 to 2024. This chart shows how Biotest Aktiengesellschaft's Defensive Interval Ratio has evolved across 17 annual periods from 2008 to 2024. As of March 2025, the ratio stands at 395 days, meaning defensive assets of €173.20 Million can fund 395 days of operations without new revenue. Read how much debt does Biotest Aktiengesellschaft carry for a breakdown of total debt and financial obligations.
Biotest Aktiengesellschaft Defensive Interval Ratio by Year (2008–2024)
Biotest Aktiengesellschaft defensive interval ratio by year from 2008 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Biotest Aktiengesellschaft from 2008 to 2024, covering 17 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see BIO3 asset base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 487 days | €213.60 Million | €438.63K/day | €- | €11.70 Million | ▲ +281 days |
| 2023 | 206 days | €217.20 Million | €1.06 Million/day | €- | €10.40 Million | ▼ -355 days |
| 2022 | 560 days | €199.90 Million | €356.71K/day | €- | €20.00 Million | ▼ -36 days |
| 2021 | 597 days | €173.90 Million | €291.51K/day | €- | €13.10 Million | ▼ -85 days |
| 2020 | 681 days | €197.10 Million | €289.32K/day | €- | €17.90 Million | ▲ +72 days |
| 2019 | 609 days | €192.00 Million | €315.07K/day | €- | €24.90 Million | ▼ -91 days |
| 2018 | 700 days | €240.90 Million | €344.11K/day | €- | €44.20 Million | ▲ +497 days |
| 2017 | 203 days | €139.70 Million | €688.22K/day | €- | €5.90 Million | ▼ -234 days |
| 2016 | 437 days | €174.70 Million | €400.00K/day | €- | €10.00 Million | ▼ -395 days |
| 2015 | 832 days | €286.70 Million | €344.66K/day | €- | €99.90 Million | ▲ +145 days |
| 2014 | 687 days | €242.70 Million | €353.15K/day | €- | €54.70 Million | ▲ +327 days |
| 2013 | 360 days | €122.70 Million | €340.55K/day | €- | €- | ▲ +143 days |
| 2012 | 217 days | €98.13 Million | €451.72K/day | €- | €-72.00K | ▼ -104 days |
| 2011 | 321 days | €129.88 Million | €404.75K/day | €- | €- | ▲ +23 days |
| 2010 | 298 days | €107.24 Million | €359.86K/day | €- | €- | ▲ +20 days |
| 2009 | 278 days | €113.30 Million | €407.61K/day | €- | €- | ▲ +270 days |
| 2008 | 8 days | €2.44 Million | €324.23K/day | €- | €- | — |